About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021 10-06-2021 at 4:05 PM EDT Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease 10-02-2021 at 1:15 PM EDT Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status 09-30-2021 at 7:30 AM EDT VIEW ALL NEWS Upcoming Events & Presentations Adaptive Biotechnologies Third Quarter Financial Results Nov 3, 2021 at 4:30 PM EDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations Morgan Stanley Global Healthcare Conference Sep 14, 2021 at 8:00 AM PDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 4, 2021 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Earnings Presentation 1.4 MB Annual Shareholder Meeting Jun 11, 2021 Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Oct 22, 2021 3:09 PM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
